These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa. van der Hoek W, Sarge-Njie R, Herremans T, Chisnall T, Okebe J, Oriero E, Versteeg B, Goossens B, van der Sande M, Kampmann B, Nwakanma D. Trop Med Int Health; 2013 Jul; 18(7):850-3. PubMed ID: 23600611 [Abstract] [Full Text] [Related]
5. Seroprevalence of Coxiella burnetii antibodies and chronic Q fever among post-mortal and living donors of tissues and cells from 2010 to 2015 in the Netherlands. van Roeden SE, Holsboer EW, Oosterheert JJ, van Kats JP, van Beckhoven J, Hogema BM, van Wijk MJ. Euro Surveill; 2018 Mar; 23(9):. PubMed ID: 29510781 [Abstract] [Full Text] [Related]
9. Q fever seroprevalence in Australia suggests one in twenty people have been exposed. Gidding HF, Peng CQ, Graves S, Massey PD, Nguyen C, Stenos J, Quinn HE, McIntyre PB, Durrheim DN, Wood N. Epidemiol Infect; 2020 Feb 05; 148():e18. PubMed ID: 32019623 [Abstract] [Full Text] [Related]
10. Short report: seroprevalence of human infection by Coxiella burnetii in Barcelona (northeast of Spain). Cardeñosa N, Sanfeliu I, Font B, Muñoz T, Nogueras MM, Segura F. Am J Trop Med Hyg; 2006 Jul 05; 75(1):33-5. PubMed ID: 16837705 [Abstract] [Full Text] [Related]
11. Prevalence of serum antibodies to Coxiella burnetii in Alaska Native Persons from the Pribilof Islands. Kersh GJ, Fitzpatrick K, Pletnikoff K, Brubaker M, Bruce M, Parkinson A. Zoonoses Public Health; 2020 Feb 05; 67(1):89-92. PubMed ID: 31705592 [Abstract] [Full Text] [Related]
12. Estimated prevalence of chronic Q fever among Coxiella burnetii seropositive patients with an abdominal aortic/iliac aneurysm or aorto-iliac reconstruction after a large Dutch Q fever outbreak. Hagenaars JC, Wever PC, van Petersen AS, Lestrade PJ, de Jager-Leclercq MG, Hermans MH, Moll FL, Koning OH, Renders NH. J Infect; 2014 Aug 05; 69(2):154-60. PubMed ID: 24647145 [Abstract] [Full Text] [Related]
13. High seroprevalence of Coxiella burnetii infection in Eastern Cantabria (Spain). Pascual-Velasco F, Montes M, Marimón JM, Cilla G. Int J Epidemiol; 1998 Feb 05; 27(1):142-5. PubMed ID: 9563708 [Abstract] [Full Text] [Related]
14. The First Serological Study of Q Fever in Humans in Lebanon. Dabaja MF, Greco G, Villari S, Bayan A, Vesco G, Gargano V, Arnone M, Hneino M, Lelli R, Ezzedine M, Berry A, Mortada H, Tempesta M, Mortada M. Vector Borne Zoonotic Dis; 2018 Mar 05; 18(3):138-143. PubMed ID: 29336692 [Abstract] [Full Text] [Related]
15. Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever. Njeru J, Henning K, Pletz MW, Heller R, Forstner C, Kariuki S, Fèvre EM, Neubauer H. BMC Infect Dis; 2016 Jun 03; 16():244. PubMed ID: 27260261 [Abstract] [Full Text] [Related]
19. [Investigation of Coxiella burnetii prevalence in women who had miscarriage and their spouses by serological and molecular methods]. Eyigör M, Gültekin B, Telli M, Odabaşı AR, Yüksel H, Demircan Sezer S, Aydın N. Mikrobiyol Bul; 2013 Apr 03; 47(2):324-31. PubMed ID: 23621732 [Abstract] [Full Text] [Related]
20. Q fever in young children, Ghana. Kobbe R, Kramme S, Kreuels B, Adjei S, Kreuzberg C, Panning M, Adjei O, Fleischer B, May J. Emerg Infect Dis; 2008 Feb 03; 14(2):344-6. PubMed ID: 18258140 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]